GE HealthCare raises 2025 guidance as Q2 revenue rises 3% to $5.0 billion
GE HealthCare reported second quarter 2025 revenue of $5.0 billion, up 3% from a year earlier, and net income attributable to the company of $486 million versus $428 million. It raised its full-year 2025 adjusted EPS guidance to $4.43 to $4.63 from $3.90 to $4.10, and its free cash flow guidance to at least $1.4 billion from at least $1.2 billion. Adjusted EBIT margin fell to 14.6% from 15.3%, which the company attributed mainly to tariffs.
Key points
- Q2 2025 revenue was $5.0 billion, up 3% reported and 2% organic year over year.
- Diluted EPS was $1.06 versus $0.93; adjusted EPS was $1.06 versus $1.00.
- 2025 adjusted EPS guidance raised to $4.43 to $4.63 from $3.90 to $4.10, including about $0.45 of tariff impact.
- Adjusted EBIT margin was 14.6% versus 15.3%, down 80 bps, impacted by tariffs.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:30 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 30, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.